Penegra should not be combined with any other PDE5 inhibitor (e.g., tadalafil, vardenafil) because the risk of severe side effects, such as hypotension and priapism, increases.
The therapeutic effect typically lasts up to four hours, though individual response can vary. The drug’s plasma half-life is about 4 hours.
Yes. Penegra is classified as a prescription-only medicine (POM) and must be obtained from a qualified prescriber.
Seek emergency medical care immediately; prolonged erections can cause permanent tissue damage if not treated promptly.
Moderate alcohol consumption is generally safe, but excessive intake may increase dizziness and reduce the medication’s effectiveness.
A heavy, fatty meal can delay absorption, potentially postponing the onset of action by up to an hour.
Some users report transient blue-tinted vision or increased light sensitivity. Persistent visual disturbances warrant urgent medical evaluation.
Men with well-controlled hypertension may use Penegra, but uncontrolled or severe hypertension is a relative contraindication. Blood pressure should be monitored.
Penegra tablets are typically imprinted with “P-50” for the 50 mg strength; other strengths carry corresponding numeric codes.
Both are PDE5 inhibitors, but sildenafil (Penegra) has a shorter duration of action (about 4 hours) compared with tadalafil, which can last up to 36 hours. Choice depends on patient preference and clinical factors.
Penegra contains sildenafil as its active component. It is marketed in the United Kingdom as a prescription-only pill for the treatment of erectile dysfunction (ED). The medication is available in strengths of 25 mg, 50 mg, and 100 mg and is regulated by the Medicines and Healthcare products Regulatory Agency (MHRA).
Sildenafil belongs to the class of phosphodiesterase-5 (PDE5) inhibitors. By blocking the PDE5 enzyme, it increases levels of cyclic guanosine-monophosphate (cGMP) within the smooth muscle of penile arteries. Elevated cGMP causes relaxation of smooth muscle and vasodilation, allowing more blood to flow into the corpora cavernosa during sexual arousal.
The drug is absorbed quickly after oral intake, reaching peak plasma concentrations in about 30-120 minutes. Its effects typically last up to four hours, though individual response varies.
Penegra is approved by the MHRA for the treatment of erectile dysfunction in adult males. The medication is indicated when a man is unable to achieve or maintain an erection sufficient for satisfactory sexual activity. It does not cure underlying disease; it facilitates the physiological response to sexual stimulation.
In some clinical studies, sildenafil has been investigated for pulmonary arterial hypertension (PAH) under the brand name Revatio. While the mechanism is similar, Penegra is not approved for PAH in the UK. Off-label use for PAH should only occur under specialist supervision and with informed risk assessment.
Note: Dosing must always be individualized by a qualified prescriber based on the patient’s health status and concomitant medications.
This article provides educational information about Penegra and is not a substitute for professional medical advice. Treatment decisions, including the use of any medication for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
